AJIRIOGHENE IGBIDE: Open Payments
NPI 1659610871 · WASHINGTON, DC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$501 in 21 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $83 · 2025 $501
Food & beverage: $473Education: $27
| Company | Payments | Amount |
|---|---|---|
| Lundbeck LLC | 11 | $260 |
| Otsuka America Pharmaceutical, Inc. | 5 | $111 |
| Teva Pharmaceuticals USA, Inc. | 2 | $38 |
| Neurocrine BioSciences, Inc. | 1 | $37 |
| Janssen Pharmaceuticals, Inc | 1 | $27 |
| E.R. Squibb & Sons, L.L.C. | 1 | $27 |
Products named: REXULTI, AUSTEDO XR, INGREZZA, INVEGA SUSTENNA, COBENFY.
Industry payments across DC — which companies pay providers there.
